There was also heterogeneity by underlying pancreatic condition, with the greatest early insulin initiation in pancreatic cancer (HR 19.48 [95% CI 17.37–21.84]) and chronic pancreatitis subtypes (HR 13.82 [95% CI 13.06–14.62]) (Figure S4). This evidence concerns the gene INS and pancreatic neoplasm.